AdvaMed Statement on the Release of FDA Rule on Laboratory-Developed Tests
May 01, 2024
May 01, 2024
WASHINGTON, May 1 -- The Advanced Medical Technology Association issued the following statement on April 30, 2024:
* * *
Today, AdvaMed, the Medtech Association, released the following statements from President and CEO Scott Whitaker and Zach Rothstein, Executive Director of AdvaMedDx, on FDA's final rule for Laboratory Developed Tests (LDTs):
"We appreciate FDA's commitment to ensuring the safety and effectiveness of in vitro diagnostic tests, regardl . . .
* * *
Today, AdvaMed, the Medtech Association, released the following statements from President and CEO Scott Whitaker and Zach Rothstein, Executive Director of AdvaMedDx, on FDA's final rule for Laboratory Developed Tests (LDTs):
"We appreciate FDA's commitment to ensuring the safety and effectiveness of in vitro diagnostic tests, regardl . . .